The Discounted Cash Flow (DCF) valuation of M2bio Sciences Inc (WUHN) is 1.55 USD. With the latest stock price at 0.00 USD, the upside of M2bio Sciences Inc based on DCF is 1550367.8%.
Based on the latest price of 0.00 USD and our DCF valuation, M2bio Sciences Inc (WUHN) is a buy. Buying WUHN stocks now will result in a potential gain of 1550367.8%.
Range | Selected | |
WACC / Discount Rate | 4.5% - 4.2% | 4.4% |
Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
Fair Price | 0.86 - 3.03 | 1.55 |
Upside | 862551.3% - 3032899.7% | 1550367.8% |
(USD in millions) | Projections | |||||
12-2012 | 12-2013 | 12-2014 | 12-2015 | 12-2016 | 12-2017 | |
Revenue | 80 | 84 | 88 | 89 | 94 | 97 |
% Growth | 37% | 5% | 4% | 2% | 6% | 3% |
Cost of goods sold | (66) | (68) | (69) | (69) | (71) | (72) |
% of Revenue | 82% | 80% | 79% | 77% | 76% | 74% |
Selling, G&A expenses | (17) | (18) | (18) | (19) | (20) | (20) |
% of Revenue | 21% | 21% | 21% | 21% | 21% | 21% |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 |
% of Revenue | 0% | 0% | 0% | 0% | 0% | 0% |
Net interest & other expenses | (7) | (8) | (8) | (8) | (9) | (9) |
% of Revenue | 9% | 9% | 9% | 9% | 9% | 9% |
Tax expense | (0) | 1 | 1 | 1 | 1 | 1 |
Tax rate | 2% | 15% | 15% | 15% | 15% | 15% |
Net profit | (10) | (7) | (7) | (5) | (5) | (3) |
% Margin | -12% | -9% | -7% | -6% | -5% | -4% |